Results 31 to 40 of about 111,576 (246)

Angioedema. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society (PTD) and Polish Society of Allergology (PTA)

open access: yesPrzegląd Dermatologiczny, 2020
Angioedema is a non-inflammatory edema of the subcutaneous tissue and/or mucosal membranes. It commonly coexists with urticaria and is considered a deep form of urticaria.
Roman Nowicki   +20 more
doaj   +1 more source

Hereditary angioedema: a disease seldom diagnosed by pediatricians

open access: yesJornal de Pediatria, 2021
Objectives: To describe the hereditary angioedema to improve awareness of this condition and reduce diagnostic delay. Data sources: Relevant articles in the MEDLINE database through PubMed.
Régis de Albuquerque Campos   +2 more
doaj   +1 more source

Outcomes of long term treatments of type I hereditary angioedema in a Turkish family [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2017
: Background: Hereditary angioedema is a rare autosomal dominantly inherited immunodeficiency disorder characterized by potentially life-threatening angioedema attacks.
Gulsen Akoglu   +3 more
doaj   +2 more sources

Hereditary angioedema

open access: yesMedicina Clínica Práctica
Edgar García Rojas   +2 more
doaj   +3 more sources

A patient with hereditary angioedema and systemic lupus erythematosus: Coincidence or coexistence?

open access: yesMedicine Science, 2020
Angioedema is classified into two major groups: mast cell-mediated (histaminergic) and bradykinin-mediated angioedema. Hereditary angioedema and acquired angioedema are well-defined groups of bradykinin-mediated angioedema. Both hereditary angioedema and
Gokhan Aytekin   +3 more
doaj   +1 more source

Successful use of lanadelumab in a patient with hereditary angioedema with normal C1 inhibitor and negative genetic testing

open access: yesJournal of Allergy and Clinical Immunology: Global, 2023
We report an approximately 80% reduction in angioedema attacks with lanadelumab, a mAb targeting plasma kallikrein, in a case of hereditary angioedema with normal C1 inhibitor levels.
Adil Adatia, MD, Bruce Ritchie, MD
doaj   +1 more source

Hereditary angioedema (HAE) in children and adolescents : a consensus on therapeutic strategies [PDF]

open access: yes, 2012
Hereditary angioedema due to C1 inhibitor (C1 esterase inhibitor) deficiency (types I and II HAE-C1-INH) is a rare disease that usually presents during childhood or adolescence with intermittent episodes of potentially life-threatening angioedema ...
Martinez-Saguer, I   +35 more
core   +2 more sources

WAO guideline for the management of hereditary angioedema [PDF]

open access: yes, 2012
Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and appropriate therapy are often unknown or not available for physicians and other health care providers.
Ruby Pawankar   +39 more
core   +1 more source

Treatment of Hereditary Angioedema [PDF]

open access: yesJournal of Investigational Allergology and Clinical Immunology, 2021
Hereditary angioedema due to C1-esterase inhibitor deficiency (C1-INH-HAE) is a rare autosomal dominant disease. In the last decade, new drugs and new indications for old drugs have played a role in the management of C1-INH-HAE. This review examines current therapy for C1-INH-HAE and provides a brief summary of drugs that are under development ...
openaire   +2 more sources

The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe) : background and methodology [PDF]

open access: yes, 2012
Background: Hereditary angioedema (HAE) is a rare but serious disease marked by swelling attacks in the extremities, face, trunk, airway, or abdominal areas that can be spontaneous or the result of trauma and other triggers.
Beusterien, Kathleen   +17 more
core   +2 more sources

Home - About - Disclaimer - Privacy